Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | RPS6KA5 | O75582 | 4/20 | 0.41 |
| ▸ | RPS6KA4 | O75676 | 3/20 | 0.41 |
| ▸ | CCR1 | P32246 | 3/20 | 0.34 |
| ▸ | CCR8 | P51685 | 3/20 | 0.34 |
| ▸ | CCR5 | P51681 | 2/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29483856 | 0.92 | — | — | |
| SCHEMBL63023 | 0.92 | — | — | |
| Fluoride SCHEMBL27460684 | 0.90 | — | — | |
| Pyrazine SCHEMBL23856033 | 0.85 | RPS6KA5 (0.35) | TDP1RPS6KA5RPS6KA4 | |
| Methyl Alcohol SCHEMBL17255950 | 0.85 | TDP1 (0.39) | TDP1RPS6KA5RPS6KA4CCR1CCR8 | |
| Cyanide SCHEMBL28136065 | 0.85 | RPS6KA5 (0.35) | TDP1RPS6KA5RPS6KA4 | |
| Pyridine SCHEMBL28152590 | 0.84 | TDP1 (0.39) | TDP1RPS6KA5RPS6KA4CCR1CCR8 | |
| SCHEMBL29236946 | 0.83 | RPS6KA5 (0.38) | TDP1RPS6KA5RPS6KA4 | |
| Pyrrole SCHEMBL6140688 | 0.82 | RPS6KA5 (0.33) | TDP1RPS6KA5RPS6KA4NR4A2 | |
| Toluene SCHEMBL28240238 | 0.81 | LMNA (0.44) | TDP1RPS6KA5RPS6KA4MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2531197-B1 | SOLID STATE FORMS OF MACROCYCLIC KINASE INHIBITORS | TRAGARA PHARMACEUTICALS INC (US) | 2017-05-17 | — | — | EP | disclosed |
| US-9120815-B2 | Solid state forms of macrocyclic kinase inhibitors | TRAGARA PHARMACEUTICALS, INC. (US) | 2015-09-01 | — | — | US | disclosed |
| US-20130150378-A1 | SOLID STATE FORMS OF MACROCYCLIC KINASE INHIBITORS | Cothera Bioscience, Inc. (KY) | 2013-06-13 | — | — | US | disclosed |
| EP-2531197-A1 | SOLID STATE FORMS OF MACROCYCLIC KINASE INHIBITORS | Tragara Pharmaceuticals, Inc. (US) | 2012-12-12 | — | — | EP | disclosed |
| WO-2011097525-A1 | SOLID STATE FORMS OF MACROCYCLIC KINASE INHIBITORS | TRAGARA PHARMACEUTICALS, INC. (US) | 2011-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130150378-A1 | SOLID STATE FORMS OF MACROCYCLIC KINASE INHIBITORS | MAP3K20, MAP3K15, MAP3K1 | TDP1 1828/4885RPS6KA5 230/4885RPS6KA4 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.